|
"sf yang"的相关文件
显示项目 6-15 / 87 (共9页)
1 2 3 4 5 6 7 8 9 > >>
每页显示[10|25|50]项目
| 中山醫學大學 |
2017-02 |
Effects of ADAMTS14 genetic polymorphism and cigarette smoking on the clinicopathologic development of hepatocellular carcinoma
|
MJ, Sheu; MJ, Hsieh; YE, Chou; PH, Wang; CB, Yeh; SF, Yang; HL, Lee; YF, Liu |
| 亞洲大學 |
2016-11 |
Prognostic Relevance of Methylenetetrahydrofolate Reductase Polymorphisms for Prostate Cancer
|
VC, Lin;VC, Lin;TL, Lu;TL, Lu;HL, Yin;HL, Yin;SF, Yang;SF, Yang;YC, Lee;YC, Lee;CC, Liu;CC, Liu;CY, Huang;CY, Huang;CC, Yu;CC, Yu;鮑柏穎;Bao, Bo-Ying;* |
| 中山醫學大學 |
2016-10 |
Functional genetic variant in the Kozak sequence of WW domain-containing oxidoreductase (WWOX) gene is associated with oral cancer risk
|
HL, Cheng; YF, Liu; CW, Su; SC, Su; MK, Chen; SF, Yang; CW, Lin |
| 中山醫學大學 |
2016-04-27 |
Lipocalin 2 prevents oral cancer metastasis through carbonic anhydrase IX inhibition and is associated with favourable prognosis.
|
CW, Lin; WE, Yang; WJ, Lee; KT, Hua; FK, Hsieh; Hsiao, M; CC, Chen; JM, Chow; MK, Chen; SF, Yang; MH, Chien |
| 中山醫學大學 |
2016-04-19 |
Melatonin inhibits TPA-induced oral cancer cell migration by suppressing matrix metalloproteinase-9 activation through the histone acetylation.
|
CM, Yeh; CW, Lin; JS, Yang; WE, Yang; SC, Su; SF, Yang |
| 中山醫學大學 |
2016-04 |
Effects of HMGB1 Polymorphisms on the Susceptibility and Progression of Hepatocellular Carcinoma
|
Wang, B; CB, Yeh; MY, Lein; CM, Su; SF, Yang; YF, Liu; CH, Tang |
| 中山醫學大學 |
2016-03-31 |
Hispolon suppresses migration and invasion of human nasopharyngeal carcinoma cells by inhibiting the urokinase-plasminogen activator through modulation of the Akt signaling pathway.
|
HY, Ho; YC, Ho; MJ, Hsieh; SF, Yang; CY, Chuang; CW, Lin; CH, Hsin |
| 中山醫學大學 |
2016-03-31 |
Cathepsin B Expression and the Correlation with Clinical Aspects of Oral Squamous Cell Carcinoma.
|
WE, Yang; CC, Ho; SF, Yang; SH, Lin; KT, Yeh; CW, Lin; MK, Chen |
| 中山醫學大學 |
2016-03-01 |
Zoledronate blocks geranylgeranylation not farnesylation to suppress human osteosarcoma U2OS cells metastasis by EMT via Rho A activation and FAK-inhibited JNK and p38 pathways.
|
HL, Cheng;CW, Lin;JS, Yang;MJ, Hsieh;SF, Yang;KH, Lu |
| 中山醫學大學 |
2016-01-11 |
Pharmacodynamic considerations in the use of matrix metalloproteinase inhibitors in cancer treatment.
|
JS, Yang;CW, Lin;SC, Su;SF, Yang |
显示项目 6-15 / 87 (共9页)
1 2 3 4 5 6 7 8 9 > >>
每页显示[10|25|50]项目
|
